Head & Neck/Thyroid Cancers
News
Lymphedema Common After Head & Neck Cancer
Major Finding: Fully 75% of patients had lymphedema.
News
Mortality Greatest With Recurrence of Papillary Type Thyroid Cancer
Major Finding: Patients who recurred with papillary thyroid cancer were significantly more likely to die of thyroid cancer as compared to...
News
FDA Approves Cetuximab for Late-Stage Head and Neck Cancer
News
Early Trial Supports Bevacizumab in Head and Neck Cancer
Major Finding: The 2-year disease-free survival rate was 75% in an as-treated population with locoregionally advanced squamous cell carcinoma of...
Conference Coverage
Screen Carotids After Head and Neck Radiation
Major Finding: The estimated risk for stenosis of the carotid arteries 3 years after irradiation for head and neck cancer was 18%.Data Source:...
Audio
Community Oncology Podcast - Vandetanib in advanced hereditary medullary thyroid cancer
Article
Community Translations Commentary Promising data, but challenges remain in selecting appropriate TKIs
News
Cancer Stage Not a Significant Factor in Radioiodine Use
Major Finding: Patient demographics and a hospital’s annual volume of thyroidectomy procedures – and not disease severity – are some of the...